Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu
Secondary Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: sulfonilamide

Sulfonamides Revisited, With an Emphasis on Dapsone

Posted on October 6, 2016 by Harald — No Comments ↓

The sulfonamide moiety is a remarkable structure giving rise to diverse drugs in arious therapeutic areas such as antibiotics, antidiabetics, diuretics and anti-inflammatory agents. In regards to antibiotics, sulfonamides are in common use as antifungals (P. jiroveci), antiparasitics (toxoplasmosis, cyclospora, isospora, Continue reading Sulfonamides Revisited, With an Emphasis on Dapsone→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Like this:

Like Loading...
Posted in Did you know...?, Recent Literature | Tagged acne, Allphase Pharma Consulting, antibiotic blog, aspirin, autoimmune diseases, Bayer, celiac disease, DADPS, dapsone, Dermatitis herpetiformis, Domagk, gluten enteropathy, Harald Reinhart, Lapdap, leprosy, Madura foot, malaria, methemoglobinemia, PCP, pemphigus, Prontosil, sulfapyridine, sulfonilamide, TMP/SMX, Trefouel | Leave a reply

Primary Sidebar Widget Area

Posts and Blogs

  • Sulopenem uUTI – Does It Suffice?
  • PUBLICATION OVERACHIEVERS
  • BLUJEPA / Gepotidacin APPROVED FOR UNCOMPLICATED UTI – 1
  • Gepotidacin ABSSSI – How to Fail Adaptively
  • A Critical Review of WHO’s List of Antibacterials in Clinical Development
  • Some Thoughts about the New Coronavirus Syndrome and its Transmission
  • Connections: From Mima/Herellea to Acinetobacter to the Double Helix to Lwoff to … CRAB
  • The Weak Correlation Between Antibiotic Action and Mortality
  • FDA Needs Radical Reform
  • The Letermovir Top-Line Results are Out – Or Are They?

Subscribe to AllphasePharma Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Tags

ABSSSI Allphase Pharma Consulting aminoglycoside antibiotic blog Avelox Bayer Ceftazidime/avibactam cIAI ciprofloxacin colistin Cubicin Cubist cUTI dalbavancin Dalvance daptomycin delafloxacin eravacycline FDA FDA Guidance fosfomycin GSK Harald Reinhart levofloxacin Merck meropenem moxifloxacin MRSA Novartis omadacycline Orbactiv oritavancin P. aeruginosa Pfizer PK/PD plazomicin QIDP solithromycin tedizolid tetracycline Tetraphase tigecycline Tygacil vancomycin VAP

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2025 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d